Cancer Genetics Inc (NASDAQ:CGIX)

10.53
Delayed Data
As of Apr 17
 +0.28 / +2.73%
Today’s Change
4.83
Today|||52-Week Range
16.88
+57.63%
Year-to-Date

Today’s Trading

Previous close10.25
Today’s open10.52
Day’s range10.00 - 10.53
Volume119,784
Average volume (3 months)72,081
Market cap$100.8M
Dividend yield--
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+50.55%
Earnings growth (this year)-16.37%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+54.30%
P/E ratioNM
Price/Sales6.19
Price/Book2.91

Competitors

 Today’s
change
Today’s
% change
GALTGalectin Therapeutic...-0.07-2.04%
GBIMGlobeImmune Inc-0.72-7.70%
ERBERBA Diagnostics Inc+0.05+1.42%
GBSNUGreat Basin Scientif...+0.60+4.44%
Data as of 3:59pm ET, 04/17/2015

Financials

Next reporting dateMay 14, 2015
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$10.2M
Annual profit (last year)-$16.6M
Net profit margin-163.18%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
President, Chief Executive Officer &
Director
Panna L. Sharma
Vice President-
Operations
Robert Fannon
Corporate headquarters
Rutherford, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers